SCHEMBL435691

SCHEMBL435691

COc1ccc(C)nc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9544209 0.95 CA12 (0.43) —
SCHEMBL5568270 0.88 DEGS1 (0.46) —
SCHEMBL11411731 0.87 LTA4H (0.50) —
SCHEMBL27855421 0.84 RXFP1 (0.51) —
SCHEMBL30981638 0.84 — —
SCHEMBL22164605 0.84 — —
SCHEMBL3265456 0.82 DYRK1A (0.56) —
SCHEMBL5562315 0.80 CHRNB2 (0.35) —
SCHEMBL19853587 0.80 MBOAT4 (0.42) —
SCHEMBL16838833 0.80 APP (0.56) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 803 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110128422-A The synthetic method of 5- methoxyl group -7- azaindole 金凯(辽宁)化工有限公司 2019-08-16 — — CN claimed
EP-3363788-A1 CANNABINOID RECEPTOR MODULATORS Arena Pharmaceuticals, Inc. (US) 2018-08-22 — — EP claimed
EP-2119717-B1 8-[3-amino-piperidin-1-yl]-xanthins, their production and utilisation as DPP IV inhibitors BOEHRINGER INGELHEIM INT (DE) 2018-01-17 — — EP claimed
US-8697868-B2 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-04-15 — — US claimed
US-20130165412-A1 CANNABINOID RECEPTOR MODULATORS ARENA PHARMACEUTICALS, INC. 2013-06-27 — — US claimed
US-20120214766-A1 CANNABINOID RECEPTOR MODULATORS ARENA PHARMACEUTICALS, INC. 2012-08-23 — — US claimed
EP-2470508-A1 CANNABINOID RECEPTOR MODULATORS Arena Pharmaceuticals, Inc. (US) 2012-07-04 — — EP claimed
WO-2011025541-A1 CANNABINOID RECEPTOR MODULATORS ARENA PHARMACEUTICALS, INC. (US) 2011-03-03 — — WO claimed
CN-101648947-A 4-(n-phenylamino)-quinazolines / quinolines as tyrosine kinase inhibitors BOEHRINGER INGELHEIM PHARMA DE 2010-02-17 — — CN claimed
US-20090137801-A1 8-[3-AMINO-PIPERIDIN-1-YL]-XANTHINES, THEIR PREPARATION AND THEIR USE AS PHARMACEUTICAL COMPOSITIONS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-05-28 — — US claimed
EP-1758905-B1 8-[3-AMINO-PIPERIDIN-1-YL]-XANTHINE, THE PRODUCTION THEREOF AND THE USE IN THE FORM OF A DDP-IV INHIBITOR BOEHRINGER INGELHEIM INT (DE) 2009-04-29 — — EP claimed
US-7501426-B2 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-03-10 — — US claimed
US-20050234108-A1 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2005-10-20 — — US claimed
CN-122036699-A THR-beta modulators and methods of use thereof 阿利戈斯治疗公司 2026-05-15 — — CN disclosed
US-12435060-B2 Acylamino bridged heterocyclic compound, and composition and application thereof BEIJING SCITECH-MQ PHARMACEUTICALS LIMITED (CN) 2025-10-07 — — US disclosed
US-20250304561-A1 MODULATORS OF THR-BETA AND METHODS OF USE THEREOF ALIGOS THERAPEUTICS, INC. (US) 2025-10-02 — — US disclosed
EP-0092903-A2 Process for preparing 2-pyridylalkyl amines SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1983-11-02 — — EP disclosed
US-4406690-A Certain aralkyloxy or aralkylthio-pyridyl-phthalimides and their use as herbicides ZOECON CORPORATION (US) 1983-09-27 — — US disclosed
US-4406689-A Certain aralkyloxy or thio-pyridyl-imidazo-pyridines and their herbicidal use ZOECON CORPORATION (US) 1983-09-27 — — US disclosed
US-4230714-A Imidazole therapeutic agents PFIZER INC. (US) 1980-10-28 — — US disclosed
Send feedback